To determine whether RhoA/LIMK/CFL-1 signaling is a key downstream axis of the HUNK/GEF-H1 suppressing the EMT of CRC cells, we next performed rescue experiments. The gene discussed is ARHGEF2; the disease is colorectal carcinoma.